Tennessee Oncology - Sarah Cannon Research Institute — Nashville, Tennessee

Tennessee Oncology - Sarah Cannon Research Institute is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 66/100 (FAIR). This profile has not yet been claimed by the site owner.

Tennessee Oncology - Sarah Cannon Research Institute has participated in 3 clinical trials with 2 currently active.

Therapeutic areas: Urothelial Carcinoma, Head and Neck Cancer, Melanoma.

Sponsors: Adaptimmune, Seattle Project Corporation.

Sponsor Feasibility Report

Trust Score: 66/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tennessee Oncology - Sarah Cannon Research Institute?

Tennessee Oncology - Sarah Cannon Research Institute has a Crixeo Trust Score of 66/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tennessee Oncology - Sarah Cannon Research Institute conducted?

Tennessee Oncology - Sarah Cannon Research Institute has 3 clinical trials on record, with 2 currently active. Their work covers Urothelial Carcinoma, Head and Neck Cancer, Melanoma.

Is Tennessee Oncology - Sarah Cannon Research Institute accredited by Crixeo Health?

Tennessee Oncology - Sarah Cannon Research Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Tennessee Oncology - Sarah Cannon Research Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.